In summary, we demonstrated that VB1 significantly inhibits UVA-induced senescence in HDFs by targeting the E58 and R65 residues of MAPK1 and effectively reduces skin photoaging in UVA-irradiated mice, indicating that VB1 could serve as a novel agent for the prevention and the potential treatment of photoaging. The gene discussed is MAPK1; the disease is neoplasm.